chrisvoncsefalvay/vaers-outcomes huggingface dataset:
One rushed to hospital months ago . Says still feeling weak. In this case it was acknowledged "vaccine" was the cause.; This is a spontaneous report from a contactable consumer or other non hcp. This consumer reported for a patient (One rushed to hospital months ago) that, a patient of unspecified age and gender received bnt162b2(PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number was not reported), via an unspecified route of administration on an unspecified date as dose number, unknown single for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient experienced one rushed to hospital months ago. The patient says still feeling weak. In this case it was acknowledged vaccine was the cause. Reporter said that I know three people who had had major adverse effects since being injected with the nonvaccine. One rushed to hospital months ago. Says still feeling weak. In this case it was acknowledged vaccine was the cause. Two others have blood clots. Regular visits to hospital. Both told they will need to be treated for life. In their case, apparently developing this life-changing condition shortly after the vaccine was just a coincidence. (I still know not a single person who has had Covid.) And it is of course just a coincidence that an ever-increasing number of younger sports people have heart attacks, on the pitch, or whilst exercising before our very eyes. It's just a coincidence that there are hundreds, if not thousands of videos in alternative media showing people dying, collapsing and in pain and terror shortly after receiving the vaccines.  The event outcome was reported as unknown.  The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.
I was sick with the following for 9 days after my 1st dose Moderna Vaccine - Migraine, Sinus infection, extremely tired, unable to focus on work
Anxiety, tremor of the hands and foot, heat sensitivity and an increase in perspiration, weight loss, enlargement of the thyroid gland, change (severe reduction) in menstrual cycles, fatigue.
Red pimples on her forehead; Red pimples around her nose; Red pimples on her chin; Feels like they're worse now; They're reddish; They look like pimples; This spontaneous case was reported by a physician (subsequently medically confirmed) and describes the occurrence of ACNE (Red pimples on her forehead), ACNE (Red pimples around her nose), ACNE (Red pimples on her chin), CONDITION AGGRAVATED (Feels like they're worse now) and RASH MACULAR (They're reddish) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 037K20A and 007M2U7) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.   On 07-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced ACNE (Red pimples on her forehead), ACNE (Red pimples around her nose), ACNE (Red pimples on her chin), CONDITION AGGRAVATED (Feels like they're worse now), RASH MACULAR (They're reddish) and ACNE (They look like pimples). At the time of the report, ACNE (Red pimples on her forehead), ACNE (Red pimples around her nose), ACNE (Red pimples on her chin), CONDITION AGGRAVATED (Feels like they're worse now), RASH MACULAR (They're reddish) and ACNE (They look like pimples) outcome was unknown.  Treatment details included Vaselin.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-142531:crosslinked
3/6/2021 9:30 pm - nausea 10:00 pm - chills and muscle spasms in stomach and legs and headache 10:30 pm - body aches and 99.2 fever and headache 3/7/2021 5:30 am - 100.1 fever and intense muscle soreness in neck, shoulders, arms, and lower back and headache 8:30 am - 98.9 fever and intense headache 10:30 am - intense headache and muscle soreness near injection sit
Narrative: pneumonia, SOB,fever, cough. Oxygen, remdesivir, dex. Discharged to home. Moderna #2
administration of expired MENACTRA with no reported adverse event; Initial information received on 15-Jun-2022 regarding an unsolicited valid non-serious case from a other health professional.  This case involves a 24 years old female patient who got expired MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE [MENACTRA] with no reported adverse event.  The patient's past vaccination(s) included MENACTRA in 2021. The patient's past medical history, medical treatment(s) and family history were not provided.  On 14-Jun-2022, the patient received 0.5 ml total dose of suspect MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE (lot U6921AA expiry date: 14-Apr-2022) via intramuscular route in the right deltoid for immunization.  On 14-JUN-2022 the patient developed a non-serious event of administration of expired menactra with no reported adverse event (expired product administered) (latency: same day) following the administration of MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE.  Action taken: not applicable.  At time of reporting, the outcome was Unknown for the event.   This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Information has been received from a physician concerning a 5 year old male who was vaccinated "at an unknown time in the past" with a dose of varicella virus vaccine live. Subsequently the patient developed shingles on his facial dermatones. Unspecified medical attention was sought and the patient was treated with acyclovir and anti itch eyedrops. His eyes became infected with conjuctivitis and he was treated in an outpatient department of the hospital for the conjunctivitis. There was no product quality complaint involved. Additional information has been requested.
Erythema over humerus, just distal to left deltoid. Firm subcutaneous nodule under site of injection. Telangiectasia just proximal to injection site. Pt. reports itchiness over patch and pain upon palpation of nodule. Cephalexin started for cellulitis.
Burning in Legs; Tingling in Legs; Can not walk properly; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of BURNING SENSATION (Burning in Legs), PARAESTHESIA (Tingling in Legs) and GAIT DISTURBANCE (Can not walk properly) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 11-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 17-Feb-2021, the patient experienced BURNING SENSATION (Burning in Legs), PARAESTHESIA (Tingling in Legs) and GAIT DISTURBANCE (Can not walk properly). At the time of the report, BURNING SENSATION (Burning in Legs), PARAESTHESIA (Tingling in Legs) and GAIT DISTURBANCE (Can not walk properly) outcome was unknown. Not Provided          Patient is taking concomitant medication but not provided. Patient is doing fine with her brain MRI. Treatment information was not provided by the reporter.
Information has been received from a 79 year old female with celecoxib allergy, "CIPERAL" allergy, latex tape allergy and sulfonamide allergy and a history of cardiac pacemaker insertion, neuropathy, hip replacement, knee arthroplasty, colostomy and hernia operations who in November 2006, was vaccinated with a dose of ZOSTAVAX. Concomitant therapy included famciclovir and "HYDROCODIENE". In November 2007, the patient experienced outbreak of shingles. It was reported that the patient's physician was almost certain to be shingles. The patient was being screened for shingles and was waiting for results. Unspecified medical was sought. At the time of report the patient had not recovered. A product quality complaint was not involved. Additional information has been requested. Additional information received from the consumer states that on 12-Nov-2007 the patient broke out with blisters on the buttocks and down the right thigh. The patient immediately called her doctor. She was examined and diagnosed with shingles. The patient stated that it was very painful. Additional information has been requested.
Pain at site at day one for 5 days. Lower back pain, bilateral hip pain at day 2 for 3 days.  Left sided neck pain and stiffness at day 2 and is ongoing. Headache at hour 3 for 2 days.
Slept 6.5 hrs straight until mom awoke to feed @ 630PM-(took 3.5 oz); then slept straight for 14 more hrs until 830AM 20SEP91 when mom woke to eat again (took 6oz);
Initial report received from a pharmacist on 15 Jan 2010: This patient was vaccinated with S-OIV FLUVIRIN of an unknown batch number, 0.5 ml on an unknown date with a vaccine stored at temperatures as low as 34 F and 35 F. No adverse event reported.
Patient received a covid vaccination that was not diluted.  Pt received 0.3 ml of the Pfizer-Biontech Covid vaccine 2023-2024 formula for ages 6 month to 5 years old, vial contains 3 doses and requires a 1.1 mL diluent to mix vaccine.
sick; sore arm; This case was reported by a consumer via interactive digital media and described the occurrence of sickness in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   In November 2021, the patient received the 2nd dose of Shingles vaccine. In November 2021, less than a week after receiving Shingles vaccine, the patient experienced sickness and pain in arm. On an unknown date, the outcome of the sickness was unknown and the outcome of the pain in arm was not recovered/not resolved.   It was unknown if the reporter considered the sickness and pain in arm to be related to Shingles vaccine.  Additional details were provided as follows: The patient self-reported this case. The age at vaccination was not reported. The patient got sick with 2nd dose and was still having a very sore arm 2 days later. The follow-up could not be possible as no contact details were available.
Treatment of COVID-19/Rebound of positive Covid test; Treatment of COVID-19/Rebound of positive Covid test; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 56-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 24Mar2021 as dose 1, single (Lot number: Er2613), on 15Apr2021 as dose 2, single (Lot number: Ew0157) and on 08Nov2021 as dose 3 (booster), single (Lot number: 301458a) at the age of 56 years for covid-19 immunisation. The patient's relevant medical history included: "Known allergies: Penicillin" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), outcome "unknown", COVID-19 (medically significant), outcome "not recovered" and all described as "Treatment of COVID-19/Rebound of positive Covid test". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (03Jul2022) Positive, notes: Rebound of positive Covid test. Therapeutic measures were taken as a result of drug ineffective, covid-19. Additional information: it was reported that Treatment of COVID-19 was stopped on 28Jun2022, patient experienced Rebound of positive Covid test on 03Jul2022.
Patient reported having pain in the right temple, nausea, vomiting, and upper abdomen pain since 4/12/21 that comes and goes. Patient spoke with provider and patient was advised to go to the nearest emergency room immediately. Patient verbalized agreement.
Information has been received from a healthcare worker concerning an unspecified patient of unknown age and tender. Two years ago in 2010, the patient was vaccinated with a dose of GARDASIL, (dose, route, frequency and lot number were not provided) and the vaccine was exposed to unspecified extreme temperature conditions prior to administration. No adverse effect reported. No treatment information was reported. The patient's outcome was unknown. Additional information has been requested.
after 10', felt short of breath and anxious.  Transferred to ED:  sx resolved after arrival/. No intervention - Observation for 4 hrs
Patient c/o difficulty swallowing about 26 minutes into her 30 minute wait. EMS was called and patient was taken to the ER.
Continuing muscle pain in both legs from hips to knees (worse on the right side) - started about March 11, 2021.  RX Lidocaine Patch 5%  & Gabapentin, with no real relief,  OTC - Naproxen - with no real relief,   Bilateral Tinnitus - started about April 29, 2021. No treatment or testing as of today - will be following up with MD.
Started to get cold with a stomach ache. Progressed to a mild fever (99) and naseua with vomiting throughout the night.
pt recvd vax; pt exp back pain & achy chest & diarrhea; MD said symptoms not related to vax but to commonly occuring viral illness;
Pt recvd 3rd dose of Engerix-B & approx 90 min later suffered a stroke; pt taken to hosp by ambulance; admitted x 4 days; recovered w/o meds;
pt recv vax & devel papular lesion;MD reported that a polymerase chain rxn on 5/6/98 revealed that the pt vesicle specimen was varicella zoster virus negative & beta globulin positive;
Redness @site nd flushing chest and neck did the same with first shot. Used oral benadryl.  3:28 Decrease in flush and pinkies Released to home. Instruct to use benadryl prn.
No additional AEs; A 17 year old  female was administered a 4th dose of GARDASIL 9; This spontaneous report was received form an office manager and refers to a 17 years old female patient. No information was provided regarding the patient's medical history, concurrent conditions, drug reactions, allergies or concomitant medications.  On 13-MAY-2021, the patient was vaccinated with a fourth dose of HPV rL1 6 11 16 18 31 33 45 52 58 VLP vaccine (yeast) (GARDASIL 9) for prophylaxis, lot # 1691180 with expiration date on 15-NOV-2022 (strength, dose number, anatomical location and route of administration were not reported). No adverse event occurred. combinationproductreport: Yes; brandname: GARDASIL 9 SYRINGE (DEVICE); commondevicename: HPV rL1 6 11 16 18 31 33 45 52 58 VLP vaccine (yeast); productcode: FMF; devicetype: SYRINGE, PISTON (FMF); manufacturername: Merck Sharp & Dohme Corp.; devicelotnumber: 1691180; expirationdate: 15-NOV-2022; deviceage and unit: 0 ; malfunction: Unknown; deviceusage: Initial; evaluatedbymfr: Not returned to manufacturer; reasonfornoneval: 81 Other; labeledsingleusedevice: No; mdcpreportability: No; mdcpreprationale: Case information does not meet criteria for reportability
Patient passed out. Blood pressure remained too low for patient to get off floor for 1% 1/2 hrs.
Severe stiffness of neck and spine. Patient could not move soon after the vaccine was given and it lasted for 4 weeks.
Headache (4/10 severity), fatigue, and pain at injection site (1/10 severity); Headache (4/10 severity), fatigue, and pain at injection site (1/10 severity); Headache (4/10 severity), fatigue, and pain at injection site (1/10 severity); This is a spontaneous report from a contactable other HCP. A 24-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration at 06Jan2021 08:30 at SINGLE DOSE for covid-19 immunization. Vaccine location was left arm. Facility where the most recent COVID-19 vaccine was administered was workplace clinic. The patient medical history was not reported. Concomitant medication included amfetamine aspartate, amfetamine sulfate, dexamfetamine saccharate, dexamfetamine sulfate (ADDERALL), calcium carbonate (TUMS), ibuprofen, tilactase (LACTAID). Patient was not diagnosed with COVID-19 prior to vaccination nor tested for COVID-19 since the vaccination. The patient didn't receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient previously took minocycline and experienced drug hypersensitivity. The patient experienced headache (4/10 severity), fatigue, and pain at injection site (1/10 severity) on 06Jan2021 13:30 with outcome of not recovered. Patient didn't receive treatment for the adverse events. The events were reported as non-serious.  Information on the lot/batch number has been requested.
might be something in that vaccine that treat pruritus; This is a spontaneous report from a contactable consumer. This consumer (patient) reported that: A 78-years-old male patient received first dose of bnt162b2 (BNT162B2, Solution injection; Batch/Lot Number: EW0162), via an unspecified route of administration, administered in Arm Right on an unspecified date as single dose and received the second dose of bnt162b2 (BNT162B2, Solution injection; Batch/Lot Number: EW0196), via an unspecified route of administration, administered in Arm Right on 10Jun2021 at 15:00 as single dose for covid-19 immunisation.  Medical history included pruritus for several years, erythema and redness for 3 or 4 years.  The patient's concomitant medications were not reported. The patient reported that when he got his vaccine my first vaccine shot around 04Jun it was on his left arm, it basically was to get his shot up and then using Calamine lotion (Treatment) because of the itch and redness and it had been there for 3 or 4 years, ok when he got his first vaccine which was 3 or 4 days the itch started disappearing and the redness disappeared and by the time he got his second vaccine it totally left out of his arm and no itch all he have is a little tissue scar. There has to be something in that vaccine to treat pruritus. He stated that he don't know if Pfizer is aware of this or not. Like he was saying it 3 or 4 days it started disappearing and he have been treating it for 3 or 4 years and he had it years ago and it came back to same spot and when he got that vaccine the first vaccine like a say it, it started disappearing in 3 or 4 days and by the time he got his second shot it totally disappeared, and all is there is a tissue scar on his arm. He stated it cleared up and it went all the way now and all you can see is you have to take a magnifying glass it was a spot as big as a eye glass on his arm and its been there for 3 or 4 years and like he said when he got his first shot within 3 or 4 days, the itch started leaving and the redness started leaving it like sand paper, its like a a raw meat in a steak and by the time he think what 10 days or 14 days after his second shot, when he got his second shot it totally disappeared that was he think 19Jun of he think and its totally gone. So, you may want to do some research on that might be something in that vaccine that treats pruritus because pruritus is a battle. So this was something people told him that he need to report this to Pfizer, might be something in that vaccine that treat pruritus. The outcome of the event was unknown.
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 71-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 22Dec2022 at 13:00 as dose 5 (booster), single (Batch/Lot number: unknown) at the age of 70 years, in right arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown), as dose 3 (booster), single (Batch/Lot number: unknown) and as dose 4 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Sulfa drug Allergy" (unspecified if ongoing). The patient's concomitant medications were not reported. Past drug history included: Morphine, reaction(s): "known_allergies Morphine", notes: known_allergies Morphine. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "Treatment of COVID-19". Therapeutic measures were taken as a result of drug ineffective, covid-19.  Clinical information: Patient treated with Paxlovid from 07May2023 to 11May2023.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
This spontaneous report was received from a nurse regarding unspecified number of patients who on an unknown date was vaccinated with PNEUMOVAX23. The nurse stated that unspecified number of patients were administered improperly stored doses of the vaccine (incorrect storage and poor quality drug administration). The outcome of the events was unknown. This case is lined to 1505USA014517 (same reporter link). Additional information has been requested.
experienced high blood pressure; wanted to go to bed and felt miserable; fever; tiredness; This spontaneous case was reported by a patient family member or friend and describes the occurrence of HYPERTENSION (experienced high blood pressure), FEELING ABNORMAL (wanted to go to bed and felt miserable), PYREXIA (fever) and FATIGUE (tiredness) in a female patient of an unknown age who received mRNA-1273 (Spikevax) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On an unknown date, the patient experienced HYPERTENSION (experienced high blood pressure), FEELING ABNORMAL (wanted to go to bed and felt miserable), PYREXIA (fever) and FATIGUE (tiredness). At the time of the report, HYPERTENSION (experienced high blood pressure), FEELING ABNORMAL (wanted to go to bed and felt miserable), PYREXIA (fever) and FATIGUE (tiredness) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood pressure measurement: high (High) High.     mRNA-1273 (Spikevax) (Unknown) dosing remained unchanged.       Concomitant drugs were not reported. Husband stated that his wife had side effects from all 3 previous doses of the Moderna COVID-19 vaccine It was reported that patient's symptoms lasted for one and a half days. Treatment medications were not provided.   This case was linked to MOD-2022-584197, MOD-2022-584194, MOD-2022-584196 (Patient Link).